article thumbnail

Mississippi Becomes 37th State to Legalize Medical Cannabis With a Law that Provides Limited Access to Patients

Americans for Safe Access

There are loopholes written into the language that will allow individual municipalities to reject the law and keep medical cannabis illegal in their jurisdictions, and the bill limits cannabis businesses to operate in industrial or agricultural zones, which limits patient access. ASA strongly opposes both of these provisions.

Access 251
article thumbnail

UK : House of Commons Library – Research Briefing – Debate on access to psilocybin treatments – Published Thursday, 18 May, 2023

Cannabis Law Report

A debate has been scheduled for 18 May on access to psilocybin treatments. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Charlotte Nichols MP, Crispin Blunt MP and Ronnie Cowan MP.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Psilocybin Patenting and the Threat to Patient Access

Cannabis Law Report

Mental health treatment is big business, with the global antidepressant drug market valued at over $13 billion in 2016. Big pharma is responding accordingly, and businesses are working to patent psilocybin products and stake their claim in the emerging market. Threat to Patient Access in Oregon.

Access 52
article thumbnail

Press Release: Rahn & Associates Launches Risk Management Solutions Specifically for Psychedelic Medicinal Businesses

Cannabis Law Report

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Eric Rahn, Managing Director. As with any niche industry still in its infancy, the risks are high.

article thumbnail

Field Trip Aims To Help Patients Access Psilocybin and MDMA Through Health Canada

Cannabis Law Report

CNSX : FTRP; OTCMKTS : FTRPF), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy through Health Canada’s Special Access Program (SAP). Field Trip Health Ltd.

Access 52
article thumbnail

How Does Cannabis Legalization Impact Health, Equity, and Economy in Michigan?

MMJ Recs

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

article thumbnail

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Cannabis Law Report

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105